36 related articles for article (PubMed ID: 15183121)
1. Deoxycytidine kinase (dCK) inhibition is synthetic lethal with BRCA2 deficiency.
Guantay L; Garro C; Siri S; Pansa MF; Ghidelli-Disse S; Paviolo N; Racca A; Nicotra V; Radu C; Bocco JL; Felice R; Jansson KH; Remlinger K; Amador A; Stronach E; Coleman K; Muelbaier M; Drewes G; Gloger I; Madauss K; García M; Gottifredi V; Soria G
Drug Resist Updat; 2023 Mar; 67():100932. PubMed ID: 36706533
[TBL] [Abstract][Full Text] [Related]
2. Development and preclinical pharmacology of a novel dCK inhibitor, DI-87.
Poddar S; Capparelli EV; Rosser EW; Gipson RM; Wei L; Le T; Jung ME; Radu C; Nikanjam M
Biochem Pharmacol; 2020 Feb; 172():113742. PubMed ID: 31812677
[TBL] [Abstract][Full Text] [Related]
3. Structural characterization of new deoxycytidine kinase inhibitors rationalizes the affinity-determining moieties of the molecules.
Nomme J; Murphy JM; Su Y; Sansone ND; Armijo AL; Olson ST; Radu C; Lavie A
Acta Crystallogr D Biol Crystallogr; 2014 Jan; 70(Pt 1):68-78. PubMed ID: 24419380
[TBL] [Abstract][Full Text] [Related]
4. 4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative Stress.
Calbert ML; Chandramouly G; Adams CM; Saez-Ayala M; Kent T; Tyagi M; Ayyadevara VSSA; Wang Y; Krais JJ; Gordon J; Atkins J; Toma MM; Betzi S; Boghossian AS; Rees MG; Ronan MM; Roth JA; Goldman AR; Gorman N; Mitra R; Childers WE; Graña X; Skorski T; Johnson N; Hurtz C; Morelli X; Eischen CM; Pomerantz RT
Mol Cancer Ther; 2024 May; 23(5):683-699. PubMed ID: 38064712
[TBL] [Abstract][Full Text] [Related]
5. The associated pyrazolopyrimidines PP1 and PP2 inhibit protein tyrosine kinase 6 activity and suppress breast cancer cell proliferation.
Shim HJ; Kim HI; Lee ST
Oncol Lett; 2017 Mar; 13(3):1463-1469. PubMed ID: 28454278
[TBL] [Abstract][Full Text] [Related]
6. Modulation of deoxycytidine kinase (dCK) and glycogen synthase kinase (GSK-3β) by anti-CD20 (rituximab) and 2-chlorodeoxyadenosine (2-CdA) in human lymphoid malignancies.
Al-Katib AM; Aboukameel A; Ebrahim A; Beck FW; Tekyi-Mensah SE; Raufi A; Ahmed Y; Mandziara M; Kafri Z
Exp Hematol Oncol; 2014; 3():31. PubMed ID: 25937997
[TBL] [Abstract][Full Text] [Related]
7. Deoxycytidine kinase augments ATM-Mediated DNA repair and contributes to radiation resistance.
Bunimovich YL; Nair-Gill E; Riedinger M; McCracken MN; Cheng D; McLaughlin J; Radu CG; Witte ON
PLoS One; 2014; 9(8):e104125. PubMed ID: 25101980
[TBL] [Abstract][Full Text] [Related]
8. New insights into the synergism of nucleoside analogs with radiotherapy.
Lee MW; Parker WB; Xu B
Radiat Oncol; 2013 Sep; 8():223. PubMed ID: 24066967
[TBL] [Abstract][Full Text] [Related]
9. 2-Chloro-2'-deoxyadenosine (2CdA) biochemical aspects of antileukemic efficacy.
Fabianowska-Majewska K; Wyczechowska D
Acta Pol Pharm; 1996; 53(4):231-9. PubMed ID: 9415193
[TBL] [Abstract][Full Text] [Related]
10. Properties and levels of deoxynucleoside kinases in normal and tumor cells; implications for chemotherapy.
Eriksson S; Arnér E; Spasokoukotskaja T; Wang L; Karlsson A; Brosjö O; Gunvén P; Julusson G; Liliemark J
Adv Enzyme Regul; 1994; 34():13-25. PubMed ID: 7942271
[TBL] [Abstract][Full Text] [Related]
11. Activation of deoxycytidine kinase by protein kinase inhibitors and okadaic acid in leukemic cells.
Smal C; Cardoen S; Bertrand L; Delacauw A; Ferrant A; Van den Berghe G; Van Den Neste E; Bontemps F
Biochem Pharmacol; 2004 Jul; 68(1):95-103. PubMed ID: 15183121
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis induced by protein phosphatase 2A (PP2A) inhibition in T leukemia cells is negatively regulated by PP2A-associated p38 mitogen-activated protein kinase.
Boudreau RT; Conrad DM; Hoskin DW
Cell Signal; 2007 Jan; 19(1):139-51. PubMed ID: 16844342
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological inhibition of the MAPK/ERK pathway increases sensitivity to 2-chloro-2'-deoxyadenosine (CdA) in the B-cell leukemia cell line EHEB.
Smal C; Lisart S; Maerevoet M; Ferrant A; Bontemps F; Van Den Neste E
Biochem Pharmacol; 2007 Feb; 73(3):351-8. PubMed ID: 17137556
[TBL] [Abstract][Full Text] [Related]
14. Biochemical pharmacology and resistance to 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine, a novel analogue of cladribine in human leukemic cells.
Lotfi K; Månsson E; Spasokoukotskaja T; Pettersson B; Liliemark J; Peterson C; Eriksson S; Albertioni F
Clin Cancer Res; 1999 Sep; 5(9):2438-44. PubMed ID: 10499616
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
